Trials / Completed
CompletedNCT04877366
Evaluate Effects of Sprinkled Format REDUCOSE in a Carbohydrate-rich, Mixed Meal on Post-prandial Glycemia
A Randomized, Double-blind, Placebo- and Active-Controlled, Single-Center, Three-time-period, Crossover Study to Evaluate the Effects of Sprinkled Format REDUCOSE on Post-Prandial Glycemic Response in Asian Patients with Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
This is a mechanistic, single-center, double-blind, placebo- and active-controlled, three-time-period, crossover study to evaluate the effect of sprinkled format REDUCOSE compared to placebo (double-blind; confirmative) and active control (open-label; acarbose - explorative) on post prandial glycemia in Asian patients with type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Dietary Supplement: Sprinkled Format REDUCOSE. | 2 G powder sprinkle containing 250 mg REDUCOSE (mulberry leaf extract - 250 mg - 5% DNJ) + fiber, vitamin D, and chromium picolinate |
| OTHER | Reference control | A placebo matching to the test product will be used as control |
| OTHER | Active comparator | Acarbose 100 mg tablet (provided in open-label format) |
Timeline
- Start date
- 2021-07-21
- Primary completion
- 2021-12-01
- Completion
- 2021-12-01
- First posted
- 2021-05-07
- Last updated
- 2024-10-15
Locations
2 sites across 2 countries: United States, Singapore
Source: ClinicalTrials.gov record NCT04877366. Inclusion in this directory is not an endorsement.